Therapeutics for COVID-19
Authors:
- Sriram KrishnaswamiSKSriram Krishnaswami
- Amparo de la PeñaAPAmparo de la Peña
- Sarah KimSKSarah Kim
- Sujatha S. MenonSMSujatha S. Menon
- 6 April 2023
- book chapter
- Published by Elsevier
- p. 282-307
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposalThe Journal of Heart and Lung Transplantation, 2020
- COVID-19: combining antiviral and anti-inflammatory treatmentsThe Lancet Infectious Diseases, 2020
- First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine, 2020
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe Lancet, 2020
- Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIMHaematologica, 2019
- An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Iatrogenic Cushing’s Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case ReportPediatrics, 2016
- Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification SystemJACC, 2016
- Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community‐acquired pneumoniaBritish Journal of Clinical Pharmacology, 2014
- 1918 Influenza: the Mother of All PandemicsEmerging Infectious Diseases, 2006